TheraRadar
← Back
Data updated: Mar 29, 2026

ATHEM

Infectious DiseaseNeurologyOphthalmology
Generics

ATHEM is a generic drug manufacturer focused on Infectious Disease, Neurology, Ophthalmology.

1995
Since
4
Drugs
-
Trials
54
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

METHAZOLAMIDE 2026-02-09
AMANTADINE HYDROCHLORIDE 2025-12-05
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 33%
1 drugs
Neurology 33%
1 drugs
Ophthalmology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

AbbVie big-pharma
Neurology, Infectious Disease, Ophthalmology
Baxter specialty
Infectious Disease, Ophthalmology
GSK big-pharma
Infectious Disease, Neurology
Roche big-pharma
Neurology, Ophthalmology
B BRAUN specialty
Infectious Disease, Ophthalmology